A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Verrini
Anna
A
Cannata
Guiseppe
G
Cozzani
Emanuele
E
Terracini
Michela
M
Parodi
Aurora
A
Rebora
Alfredo
A
D000368:Aged; D001323:Autoantibodies / Q000032:analysis*; D001324:Autoantigens / Q000032:analysis*; D001379:Azathioprine / Q000008:administration & dosage; D003598:Cytoskeletal Proteins / Q000032:analysis / Q000276:immunology; D051180:Desmoplakins; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D007381:Intermediate Filament Proteins / Q000032:analysis / Q000276:immunology; D008297:Male; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D051190:Plectin; D011241:Prednisone / Q000008:administration & dosage; D018570:Risk Assessment
D001323:Autoantibodies; D001324:Autoantigens; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D007381:Intermediate Filament Proteins; C495332:PLEC protein, human; D051190:Plectin; D001379:Azathioprine; D011241:Prednisone